Business
Organon Reports Results for the First Quarter Ended March 31, 2026
JERSEY CITY, N.J., April 30, 2026--Organon (NYSE: OGN) today announced its results for the first quarter ended March 31, 2026.
About this update from Organon & Co.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":2100,"height":315,"url":"https://media.zenfs.com/en/business-wire.com/b613ae35920ec414626058c3cbf7fab2"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/F3sA3z2YS7s6_3AC.z3PfA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTE0NA--/https://media.zenfs.com/en/business-wire.com/b613ae35920ec414626058c3cbf7fab2","width":960,"height":144},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/9uxP_CKglor7yZJp91BsSA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0zNjA-/https://media.zenfs.com/en/business-wire.com/b613ae35920ec414626058c3cbf7fab2","width":1200,"height":180}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"First quarter 2026 revenue of $1.460 billion, down 4% as-reported and down 9% excluding the impact of foreign currency.","length":119,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"First quarter 2026 diluted earnings per share of $0.55 and non-GAAP Adjusted diluted earnings per share of $0.71.","length":113,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"First quarter 2026 net income of $146 million and Adjusted EBITDA (non-GAAP) of $415 million, representing an Adjusted EBITDA margin of 28.4%.","length":142,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"On April 26, 2026, the company announced its pending merger into Sun Pharmaceutical Industries Limited (together with its subsidiaries and/or associated companies, "Sun Pharma") in an all-cash transaction (the "merger"). The merger is expected to close in early 2027, subject to customary closing conditions, including receipt of required regulatory approvals and approval by Organon stockholders.","length":417,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"In light of the pending merger, Organon will not be providing financial guidance or hosting quarterly earnings calls.","length":117,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":908,"olType":false},{"type":"text","content":"JERSEY CITY, N.J., April 30, 2026--(BUSINESS WIRE)--Organon (NYSE: OGN) today announced its results for the first quarter ended March 31, 2026.","length":143,"tagName":"p"},{"type":"text","content":"First Quarter 2026 Revenue","length":26,"tagName":"p"},...